Background To compare drug regimens across clinical trials in Parkinson's disease (PD)
conversion formulae between antiparkinsonian drugs have been developed. These are …

… Dafsari et al. also provide significant evidence of subjective sleep improvement after DBS.
The long-term benefit of sleep after DBS is supported by an early study by Lyons and Pahwa …

… Task Force,7 the original H & Y8 was used to assess the global motor dysfunction of PD. …
Continuous infusion was maintained for 17.3 ± 3.6 h/day with IJLI and 15.9 ± 3.5 h/day with …

Objective The objective of this study was to investigate whether directional deep brain
stimulation (DBS) of the subthalamic nucleus in Parkinson's disease (PD) offers increased …

… outcomes in the Mean-image against the expected outcomes in the H 0 -image using a
Wilcoxon signed rank test. After subtracting the H 0 -image from the Mean-image, we identified …

Objective Real‐life observational report of clinical efficacy of bilateral subthalamic stimulation
(STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on quality of life, …

… Dafsari was funded by the Prof. Klaus Thiemann Foundation and the Felgenhauer Foundation
… Dafsari: data acquisition, critical revision of the manuscript. Jürgen Voges: safety monitor, …

Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson’s disease improving quality of life, motor symptoms and …

Background STN-DBS is well established to improve motor symptoms and quality of life in
patients with PD. While non-motor symptoms are crucial for quality of life in these patients, …

Objective Subthalamic nucleus deep brain stimulation (STN‐DBS) in Parkinson's disease (PD)
not only stimulates focal target structures but also affects distributed brain networks. The …